Company profile
Liverpool School of Tropical Medicine
Home | LSTM
Liverpool School of Tropical Medicine is a UK company with status active founded in 1905.
Corporate ownership
Updated 07 Jul 2026 09:49
Company events
Reference milestones and recent Companies House filing stream events.
Accounts due
Accounts DueNext accounts due date
Confirmation statement due
Confirmation DueNext confirmation statement due date
Confirmation statement filed
ConfirmationLast confirmation statement made up date
Accounts filed
AccountsLast accounts made up date
Accounts With Accounts Type Full
Accounts Awaiting analysisAA | Transaction MTEyNjMwNjA0YWRpcXprY3g
Published 07 Jul 2026 04:32
Accounts With Accounts Type Full
Accounts Awaiting analysisAA | Transaction OTUyMDU2MzRhZGlxemtjeA
Published 07 Jul 2026 04:33
Accounts With Accounts Type Full
Accounts Awaiting analysisAA | Transaction MTQwMjAzMTk0YWRpcXprY3g
Published 07 Jul 2026 04:33
Accounts With Accounts Type Full
Accounts Awaiting analysisAA | Transaction MjkwNzAxNTFhZGlxemtjeA
Published 07 Jul 2026 04:32
Accounts With Accounts Type Full
Accounts Awaiting analysisAA | Transaction OTMwNzU1NTRhZGlxemtjeA
Published 07 Jul 2026 04:31
Accounts With Accounts Type Full
Accounts Awaiting analysisAA | Transaction MjA5OTk5NDlhZGlxemtjeA
Published 07 Jul 2026 04:31
Accounts With Accounts Type Full
Accounts Awaiting analysisAA | Transaction OTkzMjgwNzFhZGlxemtjeA
Published 07 Jul 2026 04:31
Accounts With Accounts Type Full Group
Accounts Awaiting analysisAA | Transaction OTkzMjg1OThhZGlxemtjeA
Published 07 Jul 2026 04:33
Selection Of Documents Registered Before January 1987
HistoricalPRE87 | Transaction MzQwMDU2NDQzMmFkaXF6a2N4 | Paper/PDF filed
Published 07 Jul 2026 04:32
Accounts With Accounts Type Full
Accounts Awaiting analysisAA | Transaction Mzk3NzA0MTJhZGlxemtjeA
Published 07 Jul 2026 04:33
Incorporated
InceptionCompany registered at Companies House
Public funding
Projects
Optimisation of a novel series of SARS-CoV-2 inhibitors
1 Jul 2022 to 31 Oct 2023
The COVID-19 pandemic is the most serious global health crisis in recent history with over 140,000 deaths in the UK and over 5 million deaths worldwide. Despite extensive vaccination programs, the virus remains transmissible with hospitalisation and mortality remaining high, both in the UK and globally. Infex Therapeutics, in partnership with the Universi...
Self-sanitising coatings to reduce healthcare associated infections
1 Jun 2022 to 30 Nov 2023
Infections are so common that they are an ever-present risk to the public. Fighting such infections is becoming continually more difficult as the resistance to antibiotics increases. For example, Hospital Acquired Infections - HAIs - increase treatment times, and in extreme cases lead to the death of a patient (an estimated 3.5% of patients who acquire a ...
Development of a Novel Rapid Sepsis Point of Care Diagnostic Device
1 Feb 2022 to 31 Jul 2023
More than 350,000 people suffer from sepsis in the UK annually, leading to 52,000 deaths. Rapid diagnosis is imperative to enable timely administration of interventional antibiotic treatment, however current methods are insufficient to empower clinicians to act within the critical first hour of admission. Early antibiotic therapy is vital to clinical outc...
Anti-viral transparent adhesive protection for Touch Screens to help in the fight against COVID-19
1 Dec 2020 to 30 Nov 2021
Society requires new solutions to reduce the probability of COVID-19 cross-infection as people resume their daily lives. However, common touch surfaces have been shown to contain significant viral and microbial contamination. The SARS-CoV-2 virus can be present on plastic and glass surfaces for several days and multiple users of the same touch surfaces cr...
Delivering Integrated Solutions for Human Infections
1 Sep 2020 to 31 Aug 2025
Adjuvant free vaccines and companion diagnostics to control emerging flaviviruses
1 May 2017 to 31 May 2018
Awaiting Public Project Summary